PerspectiveNeuroscience Thwarting Dyskinesia by Targeting mTORC1 Eric Klann*Center for Neural Science, New York University, New York, NY 10003, USA.↵*Corresponding author. E-mail, eklann{at}cns.nyu.edu See allHide authors and affiliations Science Signaling 21 Jul 2009:Vol. 2, Issue 80, pp. pe42DOI: 10.1126/scisignal.280pe42 Eric Klann Center for Neural Science, New York University, New York, NY 10003, USA.Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: eklann@cns.nyu.edu Article Figures & Data Info & Metrics eLetters PDF Article Information vol. 2 no. 80 pe42 DOI: https://doi.org/10.1126/scisignal.280pe42 PubMed: 19622830 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: Copyright © 2009, American Association for the Advancement of Science Author Information Eric Klann*Center for Neural Science, New York University, New York, NY 10003, USA.↵*Corresponding author. E-mail, eklann{at}cns.nyu.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: July 2009 to January 2021 AbstractFullPdf Jul 20092886495 Aug 20091104756 Sep 2009182929 Oct 2009253533 Nov 2009322214 Dec 2009342319 Jan 2010511214 Feb 2010151210 Mar 2010131511 Apr 201091513 May 2010191512 Jun 20105118 Jul 20101697 Aug 20102627 Sep 201020411 Oct 20102069 Nov 20103414 Dec 20102946 Jan 201132910 Feb 20112104 Mar 20112554 Apr 20111813 May 20111857 Jun 201114510 Jul 201121102 Aug 2011802 Sep 20114243 Oct 20111323 Nov 20112467 Dec 20111731 Jan 201227811 Feb 20121946 Mar 20123257 Apr 20121935 May 20121522 Jun 20121933 Jul 2012700 Aug 20122600 Sep 20121456 Oct 2012901 Nov 20121813 Dec 20122202 Jan 20133113 Feb 20131925 Mar 20131710 Apr 20132410 May 20132214 Jun 20132602 Jul 20133011 Aug 20132403 Sep 20132524 Oct 20132502 Nov 20133442 Dec 20133702 Jan 20144100 Feb 20142702 Mar 20142420 Apr 20142800 May 20144010 Jun 20145411 Jul 20142201 Aug 2014500 Sep 20141421 Oct 2014942 Nov 2014432 Dec 2014611 Jan 20152803 Feb 2015701 Mar 2015600 Apr 20151412 May 20151212 Jun 2015702 Jul 2015902 Aug 20151701 Sep 20153900 Oct 20151100 Nov 20152021 Dec 20152501 Jan 20162314 Feb 20161801 Mar 20162601 Apr 20162012 May 20161812 Jun 20163710 Jul 20164051 Aug 20161311 Sep 20163502 Oct 20162601 Nov 20162322 Dec 20161120 Jan 20171710 Feb 20172221 Mar 20171900 Apr 20171200 May 20171512 Jun 20171611 Jul 20171910 Aug 20172910 Sep 20171610 Oct 20171510 Nov 20172611 Dec 20172210 Jan 20183920 Feb 20183122 Mar 20182620 Apr 20183240 May 20185623 Jun 20182510 Jul 20182010 Aug 20181930 Sep 20182322 Oct 20182631 Nov 20181933 Dec 20182610 Jan 20191131 Feb 20191510 Mar 20191320 Apr 20191020 May 20191110 Jun 20192020 Jul 20191120 Aug 2019620 Sep 2019720 Oct 20191340 Nov 20191461 Dec 2019910 Jan 20201530 Feb 2020620 Mar 2020621 Apr 2020930 May 2020410 Jun 2020940 Jul 2020520 Aug 2020520 Sep 2020620 Oct 20201150 Nov 20201232 Dec 20201152 Jan 2021221 View Full Text
Thwarting Dyskinesia by Targeting mTORC1 By Eric Klann Science Signaling21 Jul 2009 : pe42 Blocking mTORC1 activity may decrease the unwanted involuntary movements associated with l-DOPA treatment.
Thwarting Dyskinesia by Targeting mTORC1 By Eric Klann Science Signaling21 Jul 2009 : pe42 Blocking mTORC1 activity may decrease the unwanted involuntary movements associated with l-DOPA treatment.